CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 111 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,159,000 | -34.3% | 633,418 | -4.2% | 0.00% | – |
| Q1 2022 | $1,765,000 | -38.2% | 661,063 | +0.2% | 0.00% | – |
| Q4 2021 | $2,857,000 | -15.3% | 659,863 | -0.4% | 0.00% | – |
| Q3 2021 | $3,373,000 | -22.6% | 662,665 | -3.7% | 0.00% | – |
| Q2 2021 | $4,357,000 | -66.8% | 688,324 | -59.4% | 0.00% | -100.0% |
| Q1 2021 | $13,112,000 | +191.6% | 1,696,266 | +147.1% | 0.00% | – |
| Q4 2020 | $4,496,000 | -1.5% | 686,474 | -0.0% | 0.00% | -100.0% |
| Q3 2020 | $4,566,000 | -20.2% | 686,674 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,720,000 | +8.6% | 686,674 | +0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,265,000 | -7.7% | 686,398 | +0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,702,000 | -65.0% | 686,188 | -68.9% | 0.00% | -50.0% |
| Q3 2019 | $16,274,000 | -48.2% | 2,205,101 | -21.3% | 0.00% | -50.0% |
| Q2 2019 | $31,426,000 | -5.4% | 2,800,872 | -9.4% | 0.00% | -20.0% |
| Q1 2019 | $33,225,000 | -46.2% | 3,090,673 | -24.5% | 0.01% | -50.0% |
| Q4 2018 | $61,782,000 | -18.3% | 4,091,526 | +0.1% | 0.01% | -9.1% |
| Q3 2018 | $75,621,000 | +1.8% | 4,087,603 | +25.8% | 0.01% | 0.0% |
| Q2 2018 | $74,283,000 | -9.1% | 3,249,464 | +13.1% | 0.01% | -15.4% |
| Q1 2018 | $81,721,000 | +800.1% | 2,872,432 | +567.9% | 0.01% | +1200.0% |
| Q4 2017 | $9,079,000 | +61.1% | 430,087 | +38.7% | 0.00% | 0.0% |
| Q3 2017 | $5,634,000 | +49.8% | 310,083 | +27.8% | 0.00% | 0.0% |
| Q2 2017 | $3,762,000 | +46.9% | 242,690 | +63.6% | 0.00% | – |
| Q1 2017 | $2,561,000 | +15.8% | 148,305 | -26.3% | 0.00% | – |
| Q4 2016 | $2,211,000 | +1345.1% | 201,203 | +1241.4% | 0.00% | – |
| Q2 2016 | $153,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |